Skip to main content
SpringerLink
Log in

Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae

  • Concise Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The study presented here determined the relationship between antimicrobial resistance in Streptococcus pneumoniae and the use of antimicrobial agents in 15 different European countries. Pneumococcal isolates (n = 1974) recovered from patients with community-acquired respiratory tract infections during the winter of 2004–2005 in 15 European countries were characterized. The overall percentages of isolates demonstrating intermediate or complete resistance to penicillin, erythromycin, tetracycline, trimethoprim-sulfamethoxazole (TMP-SMX) and ciprofloxacin were 24, 24.6, 19.8, 26.7 and 2%, respectively, as determined using the broth microdilution MIC method recommended by the Clinical and Laboratory Standards Institute. The overall and mean antimicrobial consumption levels (ACL)—i.e., the defined daily doses per 1,000 inhabitants per day—were obtained from the European Surveillance of Antimicrobial Consumption project for each of the 15 countries for the years 1998–2004. Using linear regression analysis, the mean annual ACL for β-lactams, macrolides, tetracyclines, TMP-SMX and fluoroquinolones in each country was compared to the country-specific resistance rates determined in 2004–2005. The rate of overall antimicrobial use in all 15 European countries was significantly associated with antimicrobial resistance in S. pneumoniae. There was variation among the different antimicrobial classes as drivers of resistance, with β-lactams having the strongest association.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Felmingham D, Grüneberg RN, the Alexander Project Group (2000) The Alexander project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. JAC 45:191–203

    PubMed  CAS  Google Scholar 

  2. Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN et al (2003) The Alexander project 1998–2002: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. JAC 52:229–246

    PubMed  CAS  Google Scholar 

  3. Klugman KP (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3:171–196

    PubMed  CAS  Google Scholar 

  4. Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Doern GV (2005) Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-hemolytic streptococci in 2002–2003: results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 25:148–156

    Article  PubMed  CAS  Google Scholar 

  5. Jones ME, Blosser-Middleton RS, Critchley IA, Karlowsky JA, Thornsberry C, Sahm DF (2003) In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000–2001. CMI 9:590–599

    PubMed  CAS  Google Scholar 

  6. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB (2001) Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000, including a comparison of resistance rates since 1994–1995. Antimicrob Agents Chemother 45:1721–1729

    Article  PubMed  CAS  Google Scholar 

  7. Goossens H, Ferech M, Vander Stichele R, Elseviers M (2005) Outpatient antibiotic use in Europe and association with resistance: a cross national database study. Lancet 365:579–587

    PubMed  Google Scholar 

  8. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R (2002) Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. JCM 40:159–164

    CAS  Google Scholar 

  9. Bronzwaer SL, Cars O, Bücholz U (2002) European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278–282

    Article  PubMed  Google Scholar 

  10. Melander E, Ekdahl K, Jönsson G, Mölstad S (2000) Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J 19:1172–1177

    Article  PubMed  CAS  Google Scholar 

  11. Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing: approved standard and informational supplement M100-S16. CLSI, Wayne, PA

  12. Chen DK, McGeer A, de Azavedo JC, Low DE (1999) Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada, Canadian Bacterial Surveillance Network. N Engl J Med 341:233–239

    Article  PubMed  CAS  Google Scholar 

  13. World Health Organization (2004) Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. WHO, Oslo, Norway

  14. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, Goossens H (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 58:401–407

    Article  PubMed  CAS  Google Scholar 

  15. Vander Stichele R, Elseviers M, Ferech M et al (2004) European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 58:419–428

    Article  Google Scholar 

Download references

Acknowledgement

This study was supported by a grant from Abbott Laboratories, Abbott Park, IL, USA.

Author information

Authors and Affiliations

  1. Division of Microbiology, Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242-1009, USA

    S. Riedel, S. E. Beekmann, K. P. Heilmann, S. S. Richter & G. V. Doern

  2. Department of Microbiology, University Clinical Hospital, Avenida Blasco Ibáñez 17, 46010, Valencia, Spain

    J. Garcia-de-Lomas

  3. Laboratory of Microbiology, University of Antwerp, Universiteitsplain 1, 2610, Antwerp, Belgium

    M. Ferech & H. Goosens

Authors
  1. S. Riedel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. E. Beekmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. P. Heilmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. S. Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Garcia-de-Lomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Ferech
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Goosens
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. V. Doern
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. V. Doern.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riedel, S., Beekmann, S.E., Heilmann, K.P. et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae . Eur J Clin Microbiol Infect Dis 26, 485–490 (2007). https://doi.org/10.1007/s10096-007-0321-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-007-0321-5

Keywords

Search

Navigation